Opposes Recommendation of Acne Drug Restrictions

New York (MedscapeWire) Sept 21 — In a speech act released twenty-four hours, the American English Lycee of Dermatology (AAD) announced its strong party to an advisory control panel good word to the US Food and Drug Governing body (FDA) that would include Accutane on a list of drugs that can only be obtained by registered physicians and patients.
The AAD is solidly behind pedagogy for both physicians and patients about the risks of using Isotretinoin. “The AAD shares the concerns of the FDA for the electrical phenomenon risk of family relationship defects if this drug is taken by women of childbearing age,” said Richard K.
Scher, MD, business executive of the AAD. “It is hard to imagine that the FDA would restrict entree to the only drug proven to effectively sustenance a common skin term like acne.
This is a part of article Opposes Recommendation of Acne Drug Restrictions Taken from "Isotretinoin (Generic Accutane) Information" Information Blog